A new leader in the ENT market
Ready to establish a new standard of care for Upper Airway, Sleep Apnea, and Snoring conditions
Leading ENT Innovation Valent Medical is ready to launch its comprehensive line of innovative and distractive products and establish a new standard of care for upper airway conditions, focused on three major ENT markets:
Rhinology / Laryngology
Snoring / Obstructive Sleep Apnea
Trans-nasal Therapeutics
Product Development Philosophy targets unmet clinical needs in large and growing attractive markets with minimally invasive products that present clinical superiority together with significant economic advantages to medical providers.
Sales Ramp-up a detailed revenue plan to achieve cash-flow and EBITDA positive in 2 years.
Valent Medical’s groundbreaking devices not only optimize medical practice but also significantly improve patients’ quality of life.
Listen below for an exciting message from Ron Hadani, the company's chief executive officer, who shares the vision for revolutionizing the ENT market and creating impactful value for investors.
Regulatory Milestones and Revenue Growth: With one FDA 510(k) clearance already secured, Valent Medical is already proving market traction and clinical viability for its first product. We are strategically positioned to achieve additional clearances across our diverse product pipeline with filling two additional FDA 510(k) submissions in Q2 of 2026. This proactive approach aims to expand our Serviceable Available Market (SAM) while driving innovation in ENT care.
Disrupting the ENT Market with Unparalleled Innovation
Valent Medical is breaking new ground in ENT care by pioneering advanced solutions across three key segments: Rhinology / Laryngology, Snoring / Obstructive Sleep Apnea (OSA), and Trans-nasal Therapeutics. Our pipeline of revolutionary devices is transforming how physicians approach treatment, delivering precision, efficiency, and patient comfort like never before. By enhancing the physician's experience and dramatically improving patient outcomes, Valent Medical is setting a bold new standard for ENT care — one that’s reshaping the future of this specialty.
Product pipeline for Rhinology / Laryngology
- 'Epic-S' diode laser Currently used for an on-going revenue generating 'Pilot program' that originally was planned for 5 clinics and grew to over 25, it proved: unprecedent versatility, clinical superiority, commercial traction, high utilization and significant gross margin - FDA cleared
- 'Ülta' diode laser platform Carrying the unique advantages of the 'Epic-S', the new 'Ülta; diode laser platform is a compact, cost-effective, idle power tool for in-office ENT surgical procedures with wide range of single use, cost effective family of handpieces and accessories - FDA Q2 2026
Advantages: Significant clinical and economic.
- The only surgical device with unique three modes of energy-tissue applications
- No bleeding, no charring, excellent coagulator
- Unobstructed direct visualization
- Only one disposable for multiple conditions
Ease of Use: Only 400 micron diameter, malleable tip for easier less traumatic access, pin-point precision resulting in less pain and shorter recovery.
Innovative Design: Single-use handpiece with integrated camera eliminating the need for use of a rigid scope. Turning rhinology into a single-hand, image-guided procedures - In progress.
Products pipeline for Snoring / Obstructive Sleep Apnea (OSA)
Snoring therapy
- ‘Elevoplasty®’ Snoring intervention kit with biodegradable implants – FDA Q2 2026
- ‘Uvulaplasty’ Shortens and stiffens uvula & soft palate with retrograde laser ablation for mild to moderate OSA – FDA Q2 2026
Mild to Severe OSA
- 'MISH' (Minimal Invasive Suspension of Hyoid and Epiglottis)
A complete surgical kit for minimal invasive procedure for suspension of the tongue and epiglottis without incision
- 'LTBR' (Laser Tongue-Base Reduction) Minimal invasive, integrated visualization, tongue-base reduction, with no tongue surface trauma
Product pipeline for Trans-nasal Therapeutics
- Trans-nasal balloon catheter Chronic Sinus Infection
Single-use catheter with a compliant balloon for a unique power irrigation of the sinus cavity for delivering treatment of chronic sinus infection.
- Trans-nasal balloon catheter Nasal cavity treatment
Single-use, balloon-based catheter and a nostril plug for sealing the nasal space between the choana and the nostril and delivering sustained treatment for the nasal cavity
- Trans-nasal balloon catheter Eustachian treatment
Single-use, compliant mini balloon-based catheter for atraumatic dilation of a dysfunctional eustachian tube
Setting the New Standard in ENT Care
Valent Medical’s cutting-edge products are redefining clinical and economic outcomes in the ENT field, delivering superior performance and setting a new benchmark for care. Valent Medical has started revolutionizing rhinology treatments with the release of its first product in the pipeline, the 'epic-S' diode laser. The FDA-cleared epic-S, is designed for precise, minimally invasive procedures. It is already gaining traction through a successful "Pilot Program“, which without sales and marketing resources, generates more than $500K in annual sales. Popularity of the product led the original goal of 5 “Pilot clinics” to an installed base of more than 25 clinics across the U.S. Our innovative rhinology solutions offer:
- Precision Energy Application: Offering unmatched three modes of energy-to-tissue delivery (Non-Contact, Contact, and Interstitial) that optimizes results across a range of procedures, ensuring consistent and superior outcomes.
- Enhanced Patient Experience: Shorter procedure times, minimized pain, and faster recoveries, elevating the standard of care for patients.
- Cost-Efficiency at its Best: A 60% to 70% procedural cost savings per procedure, driving value for both patients and healthcare providers while maximizing procedural quality and efficiency.
Valent Medical’s products deliver both clinical and economic significant benefits, setting a new standard in ENT care.
Intellectual Property
Our robust IP portfolio of over 35 patents and trademarks presents a significant value and a strong barrier to entry. Our solutions are well align with high-RVU CPT codes, offering tremendous cost savings to the clinicians with no upfront capital expense, yet resulting in gross margins exceeding 90%.
Investment Opportunity
An Interim $2M Round
Valent Medical is raising $2 million using convertible SAFE
This investment will drive commercialization, accelerate product development, and set a new standard of care, transforming how ENT procedures are performed both in-office and in the OR.
Use of Proceeds:
- Obtain FDA 510(k) clearance and establish production lines for the Ülta diode laser
- Obtain FDA 510(k) clearance and establish production line for the Elevoplasty® kit
- Conduct multi-center clinical study of PNN laser ablation
- Establish QMS, FDA registration, support growing IP, G&A
Be part of the future of ENT care and capitalize on the momentum we started creating in shaping this high-potential market!